{
  "review_date": "2026-09-23",
  "scope": "Major longevity claims in the supplied TikTok; not a systematic review or treatment advice.",
  "claims": [
    {
      "id": "mouse-result",
      "claim": "PCC1 extended remaining lifespan by about 64% in old mice",
      "label": "Reported preclinical result, with a journal warning",
      "finding": "Xu et al. (2021): mice aged 24–27 months; 91 PCC1-treated and 80 controls. Reported 64.2% longer median remaining lifespan and 9.4% longer overall lifespan. Do not convert these figures into human years.",
      "sources": [
        "https://www.nature.com/articles/s42255-021-00491-8",
        "https://www.nature.com/articles/s42255-026-01487-y"
      ]
    },
    {
      "id": "integrity",
      "claim": "The original paper is an unqualified scientific foundation",
      "label": "Important reliability qualification",
      "finding": "February 23, 2026 editorial expression of concern: Figure 6b image similarity and unavailable underlying raw data. Not a retraction or explicit invalidation of Figure 8 survival curves.",
      "sources": [
        "https://www.nature.com/articles/s42255-026-01487-y"
      ]
    },
    {
      "id": "company",
      "claim": "A Lonvi pill lets humans live to 150",
      "label": "Executive forecast, not a demonstrated outcome",
      "finding": "November 2025 NYT reporting quotes CTO Lyu Qinghua’s 150-year forecast; a separate company 100–120-year belief includes lifestyle and medical care. The academic mouse study is not a Lonvi clinical trial.",
      "sources": [
        "https://cn.nytimes.com/china/20251110/china-aging-longevity-science/zh-hant/dual/"
      ]
    },
    {
      "id": "humans",
      "claim": "Research has not reached humans",
      "label": "Too broad in light of retrieved human work",
      "finding": "A company-affiliated retrospective, uncontrolled report included 30 volunteers and analyzed 17 selected partly for improving biomarkers. Day-five marker changes do not demonstrate longer life; selection biases the inference.",
      "sources": [
        "https://cdn.shopify.com/s/files/1/0704/0512/8433/files/PCC1_Senolytic_Complex_Compound_s_Preliminary_Study_on_Regulating_Cellular_Senescence_6e575ea4-7b66-4fbe-baa2-d1850657c5a0.pdf?v=1759098908"
      ]
    },
    {
      "id": "skin-trial",
      "claim": "Registered human PCC1 research establishes longevity",
      "label": "Wrong endpoint",
      "finding": "NCT06641869, Express Rx, Inc: completed registry status, actual enrollment 74, randomized open-label design and 12-week skin outcomes. No results posted as retrieved September 23, 2026; no lifespan endpoint. Registration followed stated completion.",
      "sources": [
        "https://clinicaltrials.gov/study/NCT06641869",
        "https://clinicaltrials.gov/api/v2/studies/NCT06641869"
      ]
    },
    {
      "id": "replication",
      "claim": "Follow-up PCC1 papers confirm lifespan extension",
      "label": "Further preclinical work, not verified survival replication",
      "finding": "The 2024 PNAS study concerns retinal outcomes. The 2025 npj Aging paper concerns immune measures and grip strength and explicitly did not assess lifespan. This is a bounded review, not an exhaustive replication audit.",
      "sources": [
        "https://doi.org/10.1073/pnas.2311028121",
        "https://www.nature.com/articles/s41514-025-00222-3"
      ]
    },
    {
      "id": "product-safety",
      "claim": "Grape-seed extracts, purified PCC1 and enhanced-absorption products are equivalent and safe",
      "label": "Equivalence not established",
      "finding": "NIH and MSK describe safety and interaction limits. Health Canada’s supplemented-food assessment explicitly excludes modified forms and special carriers that change bioavailability. Product-specific Canadian licence status was not determined.",
      "sources": [
        "https://www.nccih.nih.gov/health/grape-seed-extract",
        "https://www.mskcc.org/cancer-care/integrative-medicine/herbs/grape-seed",
        "https://www.canada.ca/en/health-canada/services/food-nutrition/legislation-guidelines/acts-regulations/notices-proposal-notices-modification/modification-list-permitted-supplemental-ingredients-enable-use-grape-seed-extract/summary.html"
      ]
    }
  ]
}